美国西部犬微丝虫性皮炎遗传分析回顾性分析。

IF 1.4 3区 农林科学 Q3 DERMATOLOGY
Rebecca Parsiola, Amira Abdu, Anthea Schick, Rebecca Mount, Carine Laporte
{"title":"美国西部犬微丝虫性皮炎遗传分析回顾性分析。","authors":"Rebecca Parsiola, Amira Abdu, Anthea Schick, Rebecca Mount, Carine Laporte","doi":"10.1111/vde.70016","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Microfilarial dermatitis was described once in dogs of the western United States. The organisms were not identified.</p><p><strong>Hypothesis/objective: </strong>To identify nematodes as a cause of dermatitis and describe clinical features, treatments and therapeutic responses.</p><p><strong>Animals: </strong>Eight client-owned dogs with suspected or definitively diagnosed microfilarial dermatitis based on appropriate clinical history and therapeutic response had skin biopsy samples collected.</p><p><strong>Materials and methods: </strong>Retrospective review of electronic medical records taken between January 2010 and December 2022 from a multicentre dermatology speciality group in the United States for dogs, followed by PCR and genome sequencing of microfilariae from formalin-fixed tissue.</p><p><strong>Results: </strong>Pruritus (eight of eight), plaques (five of eight) and lesions of the head (six of eight) were commonly reported. Four had microfilariae on histopathological evaluation. One sample was genetically consistent with Cercopithifilaria bainae; another was consistent with Onchocerca lupi. Two formalin-fixed paraffin-embedded samples were not available for sequencing. Dogs received oral pulse dosing of fenbendazole (Panacur; Merck Animal Health) (mean 41 mg/kg) at 10-day intervals for 4 weeks and injectable ivermectin (Agri-Mectin; AgriLabs) (mean 0.42 mg/kg) given orally once weekly for 6 weeks. Three dogs had adverse drug events. One dog had recurrent clinical signs after experiencing full resolution. Complete resolution without recurrence was reported in two of eight dogs. The times to complete resolution were 63 days (Dog 5) and 65 days (Dog 3).</p><p><strong>Conclusions and clinical relevance: </strong>This is the first confirmed report of clinical dermatitis secondary to O. lupi microfilariae in a dog, and the second clinical description of canine C. bainae microfilarial dermatitis in the United States. Paired ivermectin and fenbendazole may be an appropriate treatment for suspected or definitively diagnosed canine microfilarial dermatitis.</p>","PeriodicalId":23599,"journal":{"name":"Veterinary dermatology","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Retrospective Review With Genetic Analysis of Canine Microfilarial Dermatitis in the Western United States.\",\"authors\":\"Rebecca Parsiola, Amira Abdu, Anthea Schick, Rebecca Mount, Carine Laporte\",\"doi\":\"10.1111/vde.70016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Microfilarial dermatitis was described once in dogs of the western United States. The organisms were not identified.</p><p><strong>Hypothesis/objective: </strong>To identify nematodes as a cause of dermatitis and describe clinical features, treatments and therapeutic responses.</p><p><strong>Animals: </strong>Eight client-owned dogs with suspected or definitively diagnosed microfilarial dermatitis based on appropriate clinical history and therapeutic response had skin biopsy samples collected.</p><p><strong>Materials and methods: </strong>Retrospective review of electronic medical records taken between January 2010 and December 2022 from a multicentre dermatology speciality group in the United States for dogs, followed by PCR and genome sequencing of microfilariae from formalin-fixed tissue.</p><p><strong>Results: </strong>Pruritus (eight of eight), plaques (five of eight) and lesions of the head (six of eight) were commonly reported. Four had microfilariae on histopathological evaluation. One sample was genetically consistent with Cercopithifilaria bainae; another was consistent with Onchocerca lupi. Two formalin-fixed paraffin-embedded samples were not available for sequencing. Dogs received oral pulse dosing of fenbendazole (Panacur; Merck Animal Health) (mean 41 mg/kg) at 10-day intervals for 4 weeks and injectable ivermectin (Agri-Mectin; AgriLabs) (mean 0.42 mg/kg) given orally once weekly for 6 weeks. Three dogs had adverse drug events. One dog had recurrent clinical signs after experiencing full resolution. Complete resolution without recurrence was reported in two of eight dogs. The times to complete resolution were 63 days (Dog 5) and 65 days (Dog 3).</p><p><strong>Conclusions and clinical relevance: </strong>This is the first confirmed report of clinical dermatitis secondary to O. lupi microfilariae in a dog, and the second clinical description of canine C. bainae microfilarial dermatitis in the United States. Paired ivermectin and fenbendazole may be an appropriate treatment for suspected or definitively diagnosed canine microfilarial dermatitis.</p>\",\"PeriodicalId\":23599,\"journal\":{\"name\":\"Veterinary dermatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Veterinary dermatology\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.1111/vde.70016\",\"RegionNum\":3,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary dermatology","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1111/vde.70016","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:微丝虫性皮炎曾在美国西部犬类中报道过一次。这些生物没有被鉴定出来。假设/目的:确定线虫是皮炎的一种病因,并描述其临床特征、治疗方法和治疗反应。动物:根据适当的临床病史和治疗反应,收集了8只疑似或明确诊断为微丝虫性皮炎的客户犬的皮肤活检样本。材料和方法:回顾性审查2010年1月至2022年12月期间来自美国多中心皮肤病专业小组的狗的电子医疗记录,然后对福尔马林固定组织中的微丝虫进行PCR和基因组测序。结果:瘙痒(8 / 8)、斑块(5 / 8)和头部病变(6 / 8)是常见的。4例经组织病理学检查发现微丝蚴。一份样本与黄蜡菌基因一致;另一个与狼盘尾丝虫一致。两个福尔马林固定石蜡包埋样品无法进行测序。给狗口服脉冲剂量的芬苯达唑(Panacur;(平均41 mg/kg),间隔10天,连续4周,注射伊维菌素(农业菌素;AgriLabs)(平均0.42 mg/kg),每周口服1次,连续6周。有三只狗出现了药物不良反应。一只狗在经历完全缓解后出现复发性临床症状。8只狗中有2只完全消退,无复发。完成解决的时间为63天(犬5)和65天(犬3)。结论及临床意义:这是美国首例犬犬红斑狼疮O. lupi微丝虫继发临床皮炎的确诊报告,也是犬犬C. bainae微丝虫皮炎的第二例临床描述。配对伊维菌素和芬苯达唑可能是适当的治疗疑似或明确诊断犬微丝性皮炎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Retrospective Review With Genetic Analysis of Canine Microfilarial Dermatitis in the Western United States.

Background: Microfilarial dermatitis was described once in dogs of the western United States. The organisms were not identified.

Hypothesis/objective: To identify nematodes as a cause of dermatitis and describe clinical features, treatments and therapeutic responses.

Animals: Eight client-owned dogs with suspected or definitively diagnosed microfilarial dermatitis based on appropriate clinical history and therapeutic response had skin biopsy samples collected.

Materials and methods: Retrospective review of electronic medical records taken between January 2010 and December 2022 from a multicentre dermatology speciality group in the United States for dogs, followed by PCR and genome sequencing of microfilariae from formalin-fixed tissue.

Results: Pruritus (eight of eight), plaques (five of eight) and lesions of the head (six of eight) were commonly reported. Four had microfilariae on histopathological evaluation. One sample was genetically consistent with Cercopithifilaria bainae; another was consistent with Onchocerca lupi. Two formalin-fixed paraffin-embedded samples were not available for sequencing. Dogs received oral pulse dosing of fenbendazole (Panacur; Merck Animal Health) (mean 41 mg/kg) at 10-day intervals for 4 weeks and injectable ivermectin (Agri-Mectin; AgriLabs) (mean 0.42 mg/kg) given orally once weekly for 6 weeks. Three dogs had adverse drug events. One dog had recurrent clinical signs after experiencing full resolution. Complete resolution without recurrence was reported in two of eight dogs. The times to complete resolution were 63 days (Dog 5) and 65 days (Dog 3).

Conclusions and clinical relevance: This is the first confirmed report of clinical dermatitis secondary to O. lupi microfilariae in a dog, and the second clinical description of canine C. bainae microfilarial dermatitis in the United States. Paired ivermectin and fenbendazole may be an appropriate treatment for suspected or definitively diagnosed canine microfilarial dermatitis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Veterinary dermatology
Veterinary dermatology 农林科学-兽医学
CiteScore
3.20
自引率
21.40%
发文量
92
审稿时长
12-24 weeks
期刊介绍: Veterinary Dermatology is a bi-monthly, peer-reviewed, international journal which publishes papers on all aspects of the skin of mammals, birds, reptiles, amphibians and fish. Scientific research papers, clinical case reports and reviews covering the following aspects of dermatology will be considered for publication: -Skin structure (anatomy, histology, ultrastructure) -Skin function (physiology, biochemistry, pharmacology, immunology, genetics) -Skin microbiology and parasitology -Dermatopathology -Pathogenesis, diagnosis and treatment of skin diseases -New disease entities
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信